View Press Releases
-
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results
-
iVexSol Closes $23.8M Series A-3 Financing; Funds to Revolutionize the Production of Lentiviral Vectors
-
Kroger Health Establishes Clinical Trial Site Network to Increase Reach and Access to Research Studies
Announcement comes with the collaboration with biopharmaceutical industry to introduce colorectal cancer clinical trial
Jan 24, 2023
-
Beacon Biosignals CEO Jacob Donoghue to Speak On Panel at Precision Medicine World Conference
Beacon Biosignals CEO Jacob Donoghue to Speak On Panel at Precision Medicine World Conference
Jan 23, 2023
-
Curebase Launches All-in-One Software and Trial Execution Package to Help Digital Therapeutics Companies Accelerate Clinical Trials
Curebase Launches All-in-One Software and Trial Execution Package to Help Digital Therapeutics Companies Accelerate Clinical Trials
Jan 23, 2023
-
Bellin Health Drives Increase in Online Self-Scheduling Appointments with Launch of New Patient Access Experience from Kyruus
Kyruus today announced that integrated healthcare delivery system, Bellin Health, recently selected Kyruus to support a new digital patient access experience on its website.
Jan 23, 2023
-
Linus Health Earns Numerous Awards as Digital Health Pioneer in Alzheimer’s and Other Dementia
Recent accolades honoring the company’s technology and workplace reflect its growing industry impact
Jan 23, 2023
-
AVIA Announces Nationwide Launch of its Digital Health Marketplace
AVIA just announced the launch of AVIA Marketplace, a vendor selection platform available for free. It provides a one-stop shop for hospital and health systems executives to research and select digital health solutions for their transformation journey.
Jan 18, 2023
-
Verana Health Study Using Curated Real-World Data to Replicate Phase III Ophthalmology Clinical Trial Published in OSLI Retina
Verana Health Study Using Curated Real-World Data to Replicate Phase III Ophthalmology Clinical Trial Published in OSLI Retina
Jan 17, 2023
-
CureSearch to lead impact study on cost, treatment benefits of molecular testing for childhood cancer patients
CureSearch for Children's Cancer is collaborating with Children's Oncology Group (COG), Labcorp Drug Development, Pfizer, UTHealth Houston School of Public Health, and Thermo Fisher Scientific on a new study to examine the economic and treatment benefits of molecular testing for childhood cancer patients.
Jan 17, 2023
-
Orbita Launches Solution to Transform Healthcare Website Search Functionality
Orbita, a leading provider of intelligent virtual assistants and workflow automation for healthcare, launched a new solution set to transform the healthcare website experience. Orbita Blaze uses conversational AI and advanced search technology to interpret and address patients’ requests promptly and with precision, so they access the information and care they need.
Jan 17, 2023
-
VisualDx Awarded Grant to Advance Global Health and Diagnostic Accuracy in Underserved Regions
The Bill & Melinda Gates Foundation awarded VisualDx a new grant to develop diagnostic tools for surveillance, detection, and triage of Neglected Tropical Diseases (NTDs) and other rare infectious diseases in India and Nigeria. This project comes on the heels of similar public health collaborations with HHS and the state of Vermont. It also marks the second Gates Foundation grant VisualDx has received, following a successful 2020 project in Botswana to provide an offline version of its clinical decision support tool for users in remote areas.
Jan 17, 2023
-
Netherlands Cancer Institute (NKI) Selects Proscia To Drive Personalized Diagnosis
Transition to modern digital pathology will improve patient care and enable new research breakthroughs
Jan 17, 2023
-
Biopharma PEG Provides PEG Products Used As ADC Linker
About Biopharma PEG As a leading manufacturer of PEG derivatives, Biochempeg is dedicated to being your most reliable partner to provide a chemical synthesis and high-quality PEG linkers. We are committed to promoting the progress of your ADC discovery and development projects. Contact us Biopharma PEG Scientific Inc. Address: 108 Water Street, Room 4D, Watertown, MA 02472, USA TEL: 1-857-366-6766 Fax: 617-206-9595 Email: sales@biochempeg.com Website:https://www.biochempeg.com/
Jan 16, 2023
-
Greenphire Appoints Owen Newman as CFO to Accelerate Company Growth
Greenphire Appoints Owen Newman as CFO to Accelerate Company Growth. The 25-year veteran brings deep expertise in financial management as the need for site and patient-centric solutions for clinical trials increases.
Jan 16, 2023
-
Tune Therapeutics Welcomes Noted Industry Leader Dr. John McHutchison to Board of Directors
Tune Therapeutics, a biotechnology company pioneering the creation of genetic tuning (epigenomic editing) therapies, today announced the addition of John McHutchison AO, MD – former CEO at Assembly Biosciences, Inc., and CSO at Gilead Sciences, Inc. – to its board of directors.
Jan 16, 2023
-
Three Ion Exchange Resins Released: Mixed Bed Resins, Chelating Resins, and Adsorbent Resins
-
Integrated Development Services for Health Care Products
-
OncoDxRx’s One-Of-A-Kind Liquid Biopsy PGA Platform Backed by Comprehensive Cancer Pathway Profiling
OncoDxRx’s one-of-a-kind liquid biopsy PGA platform is a breakthrough backed by comprehensive profiling of cancer pathways and anti-cancer drugs.
Jan 15, 2023
-
Why Are Carbon Nanomaterials Favored by Researchers?